Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark de Graaf

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|May 14, 2023
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathyBaranca Buijsers, Marjolein Garsen, Mark de Graaf, et al.
Journal of the American Society of Nephrology : JASN|December 18, 2010
γ-Adducin stimulates the thiazide-sensitive NaCl cotransporterHenrik Dimke, Pedro San-Cristobal, Mark de Graaf, et al.
The Journal of Biological Chemistry|June 30, 2010
Methionine sulfoxide reductase B1 (MsrB1) recovers TRPM6 channel activity during oxidative stressGang Cao, Kyu Pil Lee, Jenny van der Wijst, et al.
Frontiers in Molecular Biosciences|July 21, 2023
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritisBaranca Buijsers, Marissa Maciej-Hulme, Maaike Jacobs, et al.
Frontiers in Immunology|September 7, 2021
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 GlomerulopathiesMarkus A Loeven, Marissa L Maciej-Hulme, Cansu Yanginlar, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2026
Glycoinformatic profiling of label-free intact heparan sulfate oligosaccharidesMarissa L Maciej-Hulme, Jandi Kim, Elijah T Roberts, et al.
Frontiers in Immunology|October 30, 2020
Increased Plasma Heparanase Activity in COVID-19 PatientsBaranca Buijsers, Cansu Yanginlar, Aline de Nooijer, et al.
Cell Reports. Medicine|December 30, 2020
Hydroxychloroquine Inhibits the Trained Innate Immune Response to InterferonsNils Rother, Cansu Yanginlar, Rik G H Lindeboom, et al.
Ebiomedicine|March 8, 2023
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuriaMarjolein Garsen, Baranca Buijsers, Marloes Sol, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|May 14, 2023
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathyBaranca Buijsers, Marjolein Garsen, Mark de Graaf, et al.
Journal of the American Society of Nephrology : JASN|December 18, 2010
γ-Adducin stimulates the thiazide-sensitive NaCl cotransporterHenrik Dimke, Pedro San-Cristobal, Mark de Graaf, et al.
The Journal of Biological Chemistry|June 30, 2010
Methionine sulfoxide reductase B1 (MsrB1) recovers TRPM6 channel activity during oxidative stressGang Cao, Kyu Pil Lee, Jenny van der Wijst, et al.
Frontiers in Molecular Biosciences|July 21, 2023
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritisBaranca Buijsers, Marissa Maciej-Hulme, Maaike Jacobs, et al.
Frontiers in Immunology|September 7, 2021
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 GlomerulopathiesMarkus A Loeven, Marissa L Maciej-Hulme, Cansu Yanginlar, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2026
Glycoinformatic profiling of label-free intact heparan sulfate oligosaccharidesMarissa L Maciej-Hulme, Jandi Kim, Elijah T Roberts, et al.
Frontiers in Immunology|October 30, 2020
Increased Plasma Heparanase Activity in COVID-19 PatientsBaranca Buijsers, Cansu Yanginlar, Aline de Nooijer, et al.
Cell Reports. Medicine|December 30, 2020
Hydroxychloroquine Inhibits the Trained Innate Immune Response to InterferonsNils Rother, Cansu Yanginlar, Rik G H Lindeboom, et al.
Ebiomedicine|March 8, 2023
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuriaMarjolein Garsen, Baranca Buijsers, Marloes Sol, et al.
Pageof 1